An easy method for efficiently identifying proteins that interact with bioactive molecules has been developed by chemical biologists at RIKEN. This innovation, published in ChemBioChem, could help to ...

BioNTech has agreed to buy another specialist in mRNA medicines, fellow German biotech CureVac, for around $1.25 billion.

A fixture of Galveston's Strand district since 2014, Stuttgarden Tavern will serve its last pilsners and pretzels Sunday night, announcing its sudden closure.

The all-stock transaction is set to bring together two complementary German companies and build on BioNTech’s impressive track record and strong position in the global mRNA industry.

Learn about various treatment options for rheumatoid arthritis and how they help to manage symptoms, relieve pain, and slow disease progression.